CD44v6 expression is related to mesenchymal phenotype and poor prognosis in patients with colorectal cancer

Seiya Saito, Hirohisa Okabe, Masayuki Watanabe, Takatsugu Ishimoto, Masaaki Iwatsuki, Yoshifumi Baba, Youhei Tanaka, Junji Kurashige, Yuji Miyamoto, Hideo Baba

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

CD44 standard isoform (CD44s) is a cancer stem cell marker in many tumors, and is one of the CD44 isoforms.CD44v6 has been reported to correlate with tumor progression and poor prognosis in colorectal cancer. However, the relevance of CD44s and CD44v6 to epithelial-mesenchymal transition (EMT) remains unclear. Immunohistochemistry was performed to investigate the clinical importance of CD44s and CD44v6 and their relevance to EMT in 113 patients with stage II/III colorectal cancer treated by curative resection. The relevance of CD44v6 knockdown to the phenotype of colon cancer cells was examined using small interfering RNA (siRNA) specific for CD44v6 in vitro. CD44v6 expression showed a significant inverse correlation with E-cadherin expression (P=0.0007) and a positive correlation with vimentin expression (P=0.0096). A multivariate analysis showed that high CD44v6 expression was an independent poor prognostic factor for disease-free survival (P=0.01, HR=3.05) and overall survival (P=0.025, HR=3.16). The clinical significance and the relevance of CD44s expression to EMT markers was noted to a lesser extent compared to CD44v6 expression. The knockdown of CD44v6 decreased vimentin expression, cell invasion and HGF-induced cell migration, but conferred only a slight effect on E-cadherin expression in colon cancer cells (HCT116 and LoVo). CD44v6 is related to poor outcome of patients with colorectal cancer via upregulation of the mesenchymal phenotype.

Original languageEnglish
Pages (from-to)1570-1578
Number of pages9
JournalOncology reports
Volume29
Issue number4
DOIs
Publication statusPublished - Apr 2013

Fingerprint

Colorectal Neoplasms
Protein Isoforms
Epithelial-Mesenchymal Transition
Phenotype
Vimentin
Cadherins
Colonic Neoplasms
HCT116 Cells
Neoplastic Stem Cells
Small Interfering RNA
Disease-Free Survival
Cell Movement
Neoplasms
Up-Regulation
Multivariate Analysis
Immunohistochemistry
Survival

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Saito, S., Okabe, H., Watanabe, M., Ishimoto, T., Iwatsuki, M., Baba, Y., ... Baba, H. (2013). CD44v6 expression is related to mesenchymal phenotype and poor prognosis in patients with colorectal cancer. Oncology reports, 29(4), 1570-1578. https://doi.org/10.3892/or.2013.2273

CD44v6 expression is related to mesenchymal phenotype and poor prognosis in patients with colorectal cancer. / Saito, Seiya; Okabe, Hirohisa; Watanabe, Masayuki; Ishimoto, Takatsugu; Iwatsuki, Masaaki; Baba, Yoshifumi; Tanaka, Youhei; Kurashige, Junji; Miyamoto, Yuji; Baba, Hideo.

In: Oncology reports, Vol. 29, No. 4, 04.2013, p. 1570-1578.

Research output: Contribution to journalArticle

Saito, S, Okabe, H, Watanabe, M, Ishimoto, T, Iwatsuki, M, Baba, Y, Tanaka, Y, Kurashige, J, Miyamoto, Y & Baba, H 2013, 'CD44v6 expression is related to mesenchymal phenotype and poor prognosis in patients with colorectal cancer', Oncology reports, vol. 29, no. 4, pp. 1570-1578. https://doi.org/10.3892/or.2013.2273
Saito, Seiya ; Okabe, Hirohisa ; Watanabe, Masayuki ; Ishimoto, Takatsugu ; Iwatsuki, Masaaki ; Baba, Yoshifumi ; Tanaka, Youhei ; Kurashige, Junji ; Miyamoto, Yuji ; Baba, Hideo. / CD44v6 expression is related to mesenchymal phenotype and poor prognosis in patients with colorectal cancer. In: Oncology reports. 2013 ; Vol. 29, No. 4. pp. 1570-1578.
@article{04a1d47b7d0f436a80bd733779168b9e,
title = "CD44v6 expression is related to mesenchymal phenotype and poor prognosis in patients with colorectal cancer",
abstract = "CD44 standard isoform (CD44s) is a cancer stem cell marker in many tumors, and is one of the CD44 isoforms.CD44v6 has been reported to correlate with tumor progression and poor prognosis in colorectal cancer. However, the relevance of CD44s and CD44v6 to epithelial-mesenchymal transition (EMT) remains unclear. Immunohistochemistry was performed to investigate the clinical importance of CD44s and CD44v6 and their relevance to EMT in 113 patients with stage II/III colorectal cancer treated by curative resection. The relevance of CD44v6 knockdown to the phenotype of colon cancer cells was examined using small interfering RNA (siRNA) specific for CD44v6 in vitro. CD44v6 expression showed a significant inverse correlation with E-cadherin expression (P=0.0007) and a positive correlation with vimentin expression (P=0.0096). A multivariate analysis showed that high CD44v6 expression was an independent poor prognostic factor for disease-free survival (P=0.01, HR=3.05) and overall survival (P=0.025, HR=3.16). The clinical significance and the relevance of CD44s expression to EMT markers was noted to a lesser extent compared to CD44v6 expression. The knockdown of CD44v6 decreased vimentin expression, cell invasion and HGF-induced cell migration, but conferred only a slight effect on E-cadherin expression in colon cancer cells (HCT116 and LoVo). CD44v6 is related to poor outcome of patients with colorectal cancer via upregulation of the mesenchymal phenotype.",
author = "Seiya Saito and Hirohisa Okabe and Masayuki Watanabe and Takatsugu Ishimoto and Masaaki Iwatsuki and Yoshifumi Baba and Youhei Tanaka and Junji Kurashige and Yuji Miyamoto and Hideo Baba",
year = "2013",
month = "4",
doi = "10.3892/or.2013.2273",
language = "English",
volume = "29",
pages = "1570--1578",
journal = "Oncology Reports",
issn = "1021-335X",
publisher = "Spandidos Publications",
number = "4",

}

TY - JOUR

T1 - CD44v6 expression is related to mesenchymal phenotype and poor prognosis in patients with colorectal cancer

AU - Saito, Seiya

AU - Okabe, Hirohisa

AU - Watanabe, Masayuki

AU - Ishimoto, Takatsugu

AU - Iwatsuki, Masaaki

AU - Baba, Yoshifumi

AU - Tanaka, Youhei

AU - Kurashige, Junji

AU - Miyamoto, Yuji

AU - Baba, Hideo

PY - 2013/4

Y1 - 2013/4

N2 - CD44 standard isoform (CD44s) is a cancer stem cell marker in many tumors, and is one of the CD44 isoforms.CD44v6 has been reported to correlate with tumor progression and poor prognosis in colorectal cancer. However, the relevance of CD44s and CD44v6 to epithelial-mesenchymal transition (EMT) remains unclear. Immunohistochemistry was performed to investigate the clinical importance of CD44s and CD44v6 and their relevance to EMT in 113 patients with stage II/III colorectal cancer treated by curative resection. The relevance of CD44v6 knockdown to the phenotype of colon cancer cells was examined using small interfering RNA (siRNA) specific for CD44v6 in vitro. CD44v6 expression showed a significant inverse correlation with E-cadherin expression (P=0.0007) and a positive correlation with vimentin expression (P=0.0096). A multivariate analysis showed that high CD44v6 expression was an independent poor prognostic factor for disease-free survival (P=0.01, HR=3.05) and overall survival (P=0.025, HR=3.16). The clinical significance and the relevance of CD44s expression to EMT markers was noted to a lesser extent compared to CD44v6 expression. The knockdown of CD44v6 decreased vimentin expression, cell invasion and HGF-induced cell migration, but conferred only a slight effect on E-cadherin expression in colon cancer cells (HCT116 and LoVo). CD44v6 is related to poor outcome of patients with colorectal cancer via upregulation of the mesenchymal phenotype.

AB - CD44 standard isoform (CD44s) is a cancer stem cell marker in many tumors, and is one of the CD44 isoforms.CD44v6 has been reported to correlate with tumor progression and poor prognosis in colorectal cancer. However, the relevance of CD44s and CD44v6 to epithelial-mesenchymal transition (EMT) remains unclear. Immunohistochemistry was performed to investigate the clinical importance of CD44s and CD44v6 and their relevance to EMT in 113 patients with stage II/III colorectal cancer treated by curative resection. The relevance of CD44v6 knockdown to the phenotype of colon cancer cells was examined using small interfering RNA (siRNA) specific for CD44v6 in vitro. CD44v6 expression showed a significant inverse correlation with E-cadherin expression (P=0.0007) and a positive correlation with vimentin expression (P=0.0096). A multivariate analysis showed that high CD44v6 expression was an independent poor prognostic factor for disease-free survival (P=0.01, HR=3.05) and overall survival (P=0.025, HR=3.16). The clinical significance and the relevance of CD44s expression to EMT markers was noted to a lesser extent compared to CD44v6 expression. The knockdown of CD44v6 decreased vimentin expression, cell invasion and HGF-induced cell migration, but conferred only a slight effect on E-cadherin expression in colon cancer cells (HCT116 and LoVo). CD44v6 is related to poor outcome of patients with colorectal cancer via upregulation of the mesenchymal phenotype.

UR - http://www.scopus.com/inward/record.url?scp=84874674413&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874674413&partnerID=8YFLogxK

U2 - 10.3892/or.2013.2273

DO - 10.3892/or.2013.2273

M3 - Article

C2 - 23404221

AN - SCOPUS:84874674413

VL - 29

SP - 1570

EP - 1578

JO - Oncology Reports

JF - Oncology Reports

SN - 1021-335X

IS - 4

ER -